To evaluate the effect of AB4 on experimental AAA, Ang II was delivered at a dose of 1000 ng/kg/min via a subcutaneously implanted micro-osmotic pump to ApoE-/- mice. This evidence concerns the gene AGT and triple-A syndrome.